1984
DOI: 10.1016/s0140-6736(84)90559-2
|View full text |Cite
|
Sign up to set email alerts
|

Antibody to Lymphadenopathy-Associated Virus in Haemophiliacs With and Without Aids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
5
0

Year Published

1985
1985
1988
1988

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 70 publications
(6 citation statements)
references
References 0 publications
1
5
0
Order By: Relevance
“…The anti-LAV prevalence rate is proportional to the total dose of concentrate received during the last 4-year period, in agreement with other data (2,3). The observed association of anti-LAV with abnormalities of T-lymphocyte subsets is likely to reflect the association of both the parameters with concentrate consumption (4).…”
supporting
confidence: 91%
“…The anti-LAV prevalence rate is proportional to the total dose of concentrate received during the last 4-year period, in agreement with other data (2,3). The observed association of anti-LAV with abnormalities of T-lymphocyte subsets is likely to reflect the association of both the parameters with concentrate consumption (4).…”
supporting
confidence: 91%
“…Some patients, however, treated with prothrombin complex concentrates have been shown to have abnormal T4:T8 ratios,8 9 14 and the finding that small numbers of patients with haemophilia B treated with factor IX concentrates were negative for lymphadenopathy associated virus antibody (and had normal cellular immunity) needs clarification. 23 It has also been suggested that repeated antigenic challenge by factor VIII concentrate may cause the observed immunological abnormalities.30 Differences in the fractionation procedures may lead to immunochemical differences between factor VIII and prothrombin complex concentrates,13 and differences in the concentration of the HLA related protein B2 microglobulin have been implicated.31…”
Section: Resultsmentioning
confidence: 99%
“…4,17 Use of these products will hopefully prevent the infection of hemophiliacs with AIDS in the future. However, many patients with hemophilia are seropositive to HTLV-III, 10,11,14 indicating these patients have already been infected with the virus. Of 50 of our hemophilia patients examined for antibody to HTLV-III, 23 (46%) were positive, including the two patients with AIDS in this report.…”
Section: Discussionmentioning
confidence: 99%